Biological component of the NIMH Clinical Research Branch Collaborative Program on the psychobiology of depression: II. Methodology and data analysis

SYNOPSIS A preceding paper has reviewed the history, background, and rationale for this collaborative effort exploring the biologic basis of the affective disorders. This paper details the ‘flow’ of a subject through the experimental protocol, the instrumentation used to obtain the clinical and behavioural data, and the biologic methodologies employed in the analysis of the body fluids. Data management and analysis techniques developed for this study are also examined.

[1]  D. Fremstad,et al.  Plasma protein binding of drugs as influenced by blood collection methods. , 2009, Acta pharmacologica et toxicologica.

[2]  J. Mendels,et al.  Biological component of the NIMH Clinical Research Branch Collaborative Program on the psychobiology of depression: I. Background and theoretical considerations , 1980, Psychological Medicine.

[3]  R. Hirschfeld,et al.  NIMH clinical research branch collaborative program on the psychobiology of depression. , 1979, Archives of general psychiatry.

[4]  J. Endicott,et al.  A diagnostic interview: the schedule for affective disorders and schizophrenia. , 1978, Archives of general psychiatry.

[5]  E. Robins,et al.  Research diagnostic criteria: rationale and reliability. , 1978, Archives of general psychiatry.

[6]  J. B. Martin,et al.  Neural regulation of growth hormone secretion. , 1978, The New England journal of medicine.

[7]  S. Montgomery,et al.  AMITRIPTYLINE PLASMA-CONCENTRATION AND CLINICAL EFFECT A World Health Organisation Collaborative Study , 1978, The Lancet.

[8]  John M. Davis,et al.  Neuroendocrine and amine studies in affective illness , 1977, Psychoneuroendocrinology.

[9]  E. Sellers,et al.  Amitriptyline Blood Levels and Relapse , 1977, Canadian Psychiatric Association journal.

[10]  L. Gram,et al.  Plasma Level Monitoring of Tricyclic Antidepressant Therapy , 1977, Clinical pharmacokinetics.

[11]  Brown Jb.  Platelet MAO and alcoholism. , 1977 .

[12]  L. Segel,et al.  Hypothesis for origin of planktonic patchiness , 1976, Nature.

[13]  J. Jefferson,et al.  Increased erythrocyte Na+ pump and NaK-ATPase activity during lithium therapy. , 1976, Research communications in chemical pathology and pharmacology.

[14]  J. Wagner,et al.  Blood ethanol concentrations during and following constant‐rate intravenous infusion of alcohol , 1976, Clinical pharmacology and therapeutics.

[15]  J. Biggs,et al.  Electron beam ionization mass fragmentographic analysis of tricyclic antidepressants in human plasma. , 1976, Journal of pharmaceutical sciences.

[16]  L. Iversen.  Frontiers in Catecholamine Research , 1976 .

[17]  J. Maas.  Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. , 1975, Archives of general psychiatry.

[18]  S. Lal,et al.  Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone in the serum of normal men. , 1975, The Journal of clinical endocrinology and metabolism.

[19]  E. Robins,et al.  Clinical criteria for psychiatric diagnosis and DSM-III. , 1975, The American journal of psychiatry.

[20]  D. Shand,et al.  Spuriously low plasma propranolol concentrations resulting from blood collection methods , 1975, Clinical pharmacology and therapeutics.

[21]  G. Pandey,et al.  Growth hormone catecholamines in affective disease. , 1975, The American journal of psychiatry.

[22]  R. Baldessarini.  The basis for amine hypotheses in affective disorders. A critical evaluation. , 1975, Archives of general psychiatry.

[23]  A. Friedhoff.  Catecholamines and Behavior , 1975 .

[24]  T. Wehr.  Factors in Depression , 1975 .

[25]  R. Spitzer.  Glossary of Mental Disorders and Guide to Their Classification for Use in Conjunction with the International Classification of Diseases, 8th Revision , 1975 .

[26]  C. Brown,et al.  The simultaneous determination by selected ion monitoring of the levels of homovanillic, isohomovanillic, 3,4-dihydroxyphenylacetic and 3-methoxy-4-hydroxymandelic acids in single biological samples. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[27]  J. Davis,et al.  MOLECULAR ABERRATION IN PLATELET MONOAMINE OXIDASE IN SCHIZOPHRENIA , 1975, The Lancet.

[28]  D. Murphy,et al.  Platelet monoamine oxidase activity in acute schizophrenia. , 1975, The American journal of psychiatry.

[29]  D. Krieger,et al.  A sensitive bioassay for the determination of human plasma ACTH levels. , 1975, The Journal of clinical endocrinology and metabolism.

[30]  E. Shaskan,et al.  Platelet monoamine oxidase in schizophrenics , 1975, Nature.

[31]  G. Heninger,et al.  Increased human platelet monoamine oxidase activity during lithium carbonate therapy. , 1974, Life sciences.

[32]  R. Weinshilboum,et al.  Correlation of erythrocyte catechol-O-methyltransferase activity between siblings , 1974, Nature.

[33]  S. Gershon,et al.  Blood platelet monoamine oxidase activity in psychiatric patients. , 1974, The American journal of psychiatry.

[34]  J. Mendels,et al.  Alterations in cell membrane activity in depression. , 1974, The American journal of psychiatry.

[35]  T. Itil,et al.  Video methodology for research in psychopathology and psychopharmacology: Rationale and application. , 1974, Archives of general psychiatry.

[36]  G. Sedvall,et al.  Simultaneous quantification of homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid by mass fragmentography. , 1974, Life sciences.

[37]  A. Frantz,et al.  Growth hormone and prolactin in unipolar and bipolar depressed patients: responses to hypoglycemia and L-dopa. , 1973, The American journal of psychiatry.

[38]  S. Lal,et al.  Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum. , 1973, The Journal of clinical endocrinology and metabolism.

[39]  J. Maas,et al.  THE IDENTIFICATION OF DEPRESSED PATIENTS WHO HAVE A DISORDER OF NE METABOLISM AND/OR DISPOSITION , 1973 .

[40]  H. Lebovitz,et al.  Inhibition of hypoglycemia-induced growth hormone secretion by the serotonin antagonists cyproheptadine and methysergide. , 1973, The New England journal of medicine.

[41]  D. E. Redmond,et al.  Excretion of catecholamine metabolites following intraventricular injection of 6-hydroxydopamine in the Macaca speciosa. , 1973, European journal of pharmacology.

[42]  K. Lamborn,et al.  Genetic control of platelet and plasma monoamine oxidase activity. , 1973, Archives of general psychiatry.

[43]  J. Schildkraut.  Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings. , 1973, The American journal of psychiatry.

[44]  G. Luisetto,et al.  A simplified method to determine ultrafiltrable plasma magnesium. Normal values and preliminary results in hyper- and hypothyroidism. , 1973, Clinica chimica acta; international journal of clinical chemistry.

[45]  L. Wetterberg,et al.  Catechol‐O‐methyltransferase activity in erythrocytes in Down's syndrome , 1973, Clinical genetics.

[46]  J. Davis,et al.  Depressive illness : some research studies , 1973 .

[47]  J. Maas,et al.  Urinary Catecholamine Metabolites during Behavioral Changes in a Patient with Manic-Depressive Cycles , 1973, Science.

[48]  P. Bushnell,et al.  3-methoxy-4-hydroxyphenylglycol excretion and behavioural changes in rat and monkey after central sympathecomy with 6-hydroxydopamine. , 1972, Nature: New biology.

[49]  J. Sassin,et al.  Growth Hormone Responses to L-Dopa in Depressed Patients , 1972, Science.

[50]  D. Murphy,et al.  Reduced Monoamine Oxidase Activity in Blood Platelets from Schizophrenic Patients , 1972, Nature.

[51]  D. Murphy,et al.  Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients. , 1972, The American journal of psychiatry.

[52]  R. Baldessarini,et al.  S-adenosylmethionine and catechol-O-methyl-transferase in schizophrenia. , 1972, The American journal of psychiatry.

[53]  J. Maas,et al.  Catecholamine metabolism, depressive illness, and drug response. , 1972, Archives of general psychiatry.

[54]  J. Mendels,et al.  A method for the determination of sodium, potassium, magnesium and lithium concentrations in erythrocytes. , 1972, Clinica chimica acta; international journal of clinical chemistry.

[55]  G. Sampson,et al.  Daily variations of the urine content of 3-methoxy-4-hydroxyphenylglycol in two manic-depressive patients , 1972, Psychological Medicine.

[56]  E. Gershon,et al.  Differential catechol-O-methyltransferase activity in unipolar and bipolar affective illness. , 1971, Archives of general psychiatry.

[57]  J. Finkelstein,et al.  Growth Hormone Responses in Depressive Illness: I. Response to Insulin Tolerance Test , 1971 .

[58]  Maas Jw,et al.  The metabolism of circulating norepinephrine by human subjects. , 1971 .

[59]  J. Axelrod,et al.  Methyltransferase enzymes in red blood cells. , 1971, The Journal of pharmacology and experimental therapeutics.

[60]  H. Lebovitz,et al.  Stimulation of human-growth-hormone secretion by L-dopa. , 1970, The New England journal of medicine.

[61]  D. Dunner,et al.  Reduced Catechol-O-Methyltransferase Activity in Red Blood Cells of Women with Primary Affective Disorder , 1970, Science.

[62]  J. Maas,et al.  An improved procedure of 3-methoxy-4-hydroxyphenyl-ethylene glycol determination by gas-liquid chromatography. , 1970, Analytical biochemistry.

[63]  R. Himsworth.  Hypothalamic control of adrenaline secretion in response to insufficient glucose , 1970, The Journal of physiology.

[64]  J. Schildkraut,et al.  Catecholamine metabolism in affective disorders—III , 1970 .

[65]  J. Schildkraut,et al.  Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate. , 1970, Journal of psychiatric research.

[66]  A. Coppen,et al.  Plasma Magnesium and Calcium in Depression , 1969, British Journal of Psychiatry.

[67]  G. Heninger,et al.  Insulin tolerance test in depression. , 1969, Archives of general psychiatry.

[68]  T. Hökfelt,et al.  Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. , 1969, European journal of pharmacology.

[69]  A. Raskin,et al.  REPLICATION OF FACTORS OF PSYCHOPATHOLOGY IN INTERVIEW, WARD BEHAVIOR AND SELF‐REPORT RATINGS OF HOSPITALIZED DEPRESSIVES , 1969, The Journal of nervous and mental disease.

[70]  S. Berson,et al.  Radioimmunoassay of ACTH in plasma. , 1968, The Journal of clinical investigation.

[71]  J. Maas,et al.  In vivo studies of the metabolism of norepinephrine in the central nervous system. , 1968, The Journal of pharmacology and experimental therapeutics.

[72]  J. Maas,et al.  3-Methoxy-4-hydroxy phenylglycol (MHPG) excretion in depressive states. A pilot study. , 1968, Archives of general psychiatry.

[73]  R. Donald.  Application of the coated charcoal separation method to the radio-immunoassay of plasma corticotrophin. , 1968, The Journal of endocrinology.

[74]  W. Blackard,et al.  Adrenergic receptor control mechanism for growth hormone secretion. , 1968, The Journal of clinical investigation.

[75]  M. Hamilton,et al.  Development of a rating scale for primary depressive illness. , 1967, The British journal of social and clinical psychology.

[76]  I. Glynn,et al.  The stoicheiometry of the sodium pump , 1967, The Journal of physiology.

[77]  B. Murphy,et al.  Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay. , 1967, The Journal of clinical endocrinology and metabolism.

[78]  C. Albright,et al.  Resolution of Pump and Leak Components of Sodium and Potassium Ion Transport in Human Erythrocytes , 1967, The Journal of general physiology.

[79]  S. Kety,et al.  Biogenic Amines and Emotion , 1967, Science.

[80]  S. Sawano,et al.  Blockade of release of growth hormone by brain norepinephrine depletors. , 1967, Endocrinology.

[81]  W. Bunney,et al.  Norepinephrine in depressive reactions. A review. , 1965, Archives of general psychiatry.

[82]  J. Schildkraut,et al.  The catecholamine hypothesis of affective disorders: a review of supporting evidence. , 1965, The American journal of psychiatry.

[83]  H. Landis,et al.  Brain Norepinephrine and Behavior: A Behavioral and Kinetic Study , 1965, Psychosomatic medicine.

[84]  J. Glowinski,et al.  METABOLISM OF [3H]NOREPINEPHRINE IN THE RAT BRAIN , 1965, Journal of neurochemistry.

[85]  R. Horton,et al.  PHYSIOLOGY OF URINARY CORTISOL EXCRETION. , 1964, The Journal of clinical endocrinology and metabolism.

[86]  M. D. Armstrong,et al.  THE PHAGOCYTIC ACTIVITY OF POLYMORPHONUCLEAR LEUKOCYTES OBTAINED FROM PATIENTS WITH DIABETES MELLITUS. , 1964 .

[87]  W. Rummel,et al.  [The action of adrenaline on the fatigued cat soleus muscle]. , 1964, Experientia.

[88]  J. Cade.  A SIGNIFICANT ELEVATION OF PLASMA MAGNESIUM LEVELS IN SCHIZOPHRENIA AND DEPRESSIVE STATES , 1964, The Medical journal of Australia.

[89]  A. Hodgkin,et al.  The effects of injecting ‘energy‐rich’ phosphate compounds on the active transport of ions in the giant axons of Loligo , 1960, The Journal of physiology.

[90]  J. Zubin,et al.  A ward behavior rating scale for mental hospital patients. , 1960, Journal of clinical psychology.

[91]  Gibbons Jl.  Total body sodium and potassium in depressive illness. , 1960 .

[92]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[93]  J. Axelrod,et al.  Enzymatic O-methylation of epinephrine and other catechols. , 1958, The Journal of biological chemistry.

[94]  H. Taussky,et al.  ON THE COLORIMETRIC DETERMINATION OF CREATININE BY THE JAFFE REACTION , 1945 .

[95]  J. Mendels,et al.  Transfer of sodium ions across the erythrocyte membrane in manic-depressive illness: treatment with lithium carbonate. , 1978, Life sciences.

[96]  Trevor R. Norman,et al.  Should plasma level monitoring of tricyclic antidepressants be introduced in clinical practice? , 1978, Communications in psychopharmacology.

[97]  M. Lipton,et al.  Psychopharmacology : a generation of progress , 1978 .

[98]  E. Robins,et al.  Effect of Vacutainer stoppers on plasma tricyclic levels: a reevaluation. , 1978, Communications in psychopharmacology.

[99]  AMITRIPTYLINE PLASMA CONCENTRATION AND CLINICAL EFFECT , 1978 .

[100]  J. Mendels,et al.  Transfer of lithium ions across the erythrocyte membrane. , 1977, Communications in psychopharmacology.

[101]  J. Mendels,et al.  Reduced levels of tricyclic antidepressants in plasma from Vacutainers. , 1977, Communications in psychopharmacology.

[102]  J. Maas.  The effects of psychopharmacological agents on central nervous system amine metabolism in man. , 1977, Annual review of pharmacology and toxicology.

[103]  J. B. Brown.  Platelet MAO and alcoholism. , 1977, The American journal of psychiatry.

[104]  E. Sachar.  Hormones, behavior, and psychopathology , 1976 .

[105]  F. Goodwin,et al.  Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline. , 1975, Archives of general psychiatry.

[106]  J. Sassin,et al.  Growth hormone responses to hypoglycemia in postmenopausal depressed women. , 1975, Archives of general psychiatry.

[107]  F. Goodwin,et al.  Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis. , 1975, Research publications - Association for Research in Nervous and Mental Disease.

[108]  D. Murphy,et al.  The Catecholamines: Possible Role in Affect, Mood, and Emotional Behavior in Man and Animals , 1975 .

[109]  Stahl Sm,et al.  Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients. , 1974, Research communications in chemical pathology and pharmacology.

[110]  J. Rybakowski,et al.  Red blood cell lithium index in patients with affective disorders in the course of lithium prophylaxis. , 1974, International pharmacopsychiatry.

[111]  L. Covi,et al.  The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions. , 1974, Modern problems of pharmacopsychiatry.

[112]  D. Janowsky,et al.  Pharmacology—The Biology of Lithium , 1973 .

[113]  J. Feighner,et al.  Diagnostic criteria for use in psychiatric research. , 1972, Archives of general psychiatry.

[114]  E. Gershon,et al.  Effects of Tricyclic Antidepressants on Norepinephrine Metabolism: Basic and Clinical Studies , 1971 .

[115]  B. Ho,et al.  Brain Chemistry and Mental Disease , 1971, Advances in Behavioral Biology.

[116]  M. D. Armstrong,et al.  QUANTITATIVE DETERMINATION OF METANEPHRINE AND NORMETANEPHRINE IN URINE. , 1964, The Journal of laboratory and clinical medicine.

[117]  J. Skou.  Further investigations on a Mg++ + Na+-activated adenosintriphosphatase, possibly related to the active, linked transport of Na+ and K+ across the nerve membrane , 1960 .

[118]  J. Gibbons.  Total body sodium and potassium in depressive illness. , 1960, Clinical science.